Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-140393
Filing Date
2024-12-26
Accepted
2024-12-26 16:02:31
Documents
1
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3906
  Complete submission text file 0000950170-24-140393.txt   5474
Mailing Address 35 OAK HILL ROAD FAYVILLE MA 01745
Business Address
Keson-Brookes Maiken (Reporting) CIK: 0001693805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41837 | Film No.: 241581027

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Issuer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)